Open Access

ARTICLE

CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors

BIN ZHANG^1,#, JIANYI ZHAO^3,#, YONGZHI WANG^2,#, HUA XU¹, BO GAO¹, GUANGNING ZHANG¹, BIN HAN¹, GUOHONG SONG¹, JUNCHEN ZHANG^1,*, WEI MENG^1,*

1 Department of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, China
2 Department of Neurosurgery, The City Peoples’ Hospital of Fuyang, Fuyang, China
3 Brain Injury Center, Department of Neurosurgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

* Corresponding Authors: Junchen Zhang, ; Wei Meng,
# These authors contributed equally to this work